Intervento dell’on Donatella Poretti parlamentare radicale della Rosa nel Pugno, segretaria della Commissione Affari Sociali, membro di giunta dell’Associazione Coscioni
Esprimo il mio apprezzamento sull’iniziativa dei 20 consiglieri comunali di Torino che hanno chiesto la sperimentazione delle "safe injection rooms", anche chiamate narcosale. Chi nega l’efficacia di questo strumento nella lotta agli effetti della droga nega la realta’ dei fatti, affermata scientificamente da innumerevoli ricerche (1). Le narcosale sono uno dei pochi modi in cui gli operatori nel campo delle tossicodipendenze possono entrare in contatto con chi usa droghe da iniezione come l’eroina, offrendo loro la possibilita’ di curarsi. Inoltre la narcosala puo’ offrire altri importantissimi servizi, come siringhe pulite, controllo di sostanze e dosi, supervisione medica -tre strumenti che serviranno (come gia’ in Spagna, Svizzera, Germania, Australia, Canada, etc.) a ridurre drasticamente le morti per overdosi ed il danno alla salute dei tossicodipendenti.
Accolgo con speranza le reazioni del sindaco di Torino, Sergio Chiamparino, e del ministro della Salute, Livia Turco, entrambi favorevoli alla sperimentazione. Mi auguro di tutto cuore che anche in Parlamento, come gia’ nel Consiglio comunale di Torino, la maggioranza voglia finalmente mostrare segni di vita in materia di tossicodipendenza.
(1) questi alcuni articoli sull’efficacia delle politiche di riduzione del danno:
– Betteridge G., Vancouver safe injection facility: more positive results. HIV AIDS Policy Law Rev. 2006 Apr;11(1):19-20.
– Broadhead, Robert S., Thomas Kerr, Jean-Paul C. Grund, and Frederick L. Altice, "Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives," Journal of Drug Issues (Tallahassee, FL: Florida State University, Winter 2002), Vol. 32, No. 1
– Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries, Institute of Medicine, National Academy of Sciences, "Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence" (Washington, DC: National Academy Press, 2006)
– de Wit, Ardine and Jasper Bos, "Cost-Effectiveness of Needle and Syringe Programmes: A Review of the Literature," in Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options, Johannes Jager, Wien Limburg, Mirjam Kretzschmar, Maarten Postma, Lucas Wiessing (eds.), European Monitoring Centre on Drugs and Drug Addiction, 2004.
– Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001;15(11):1329-41.
– Hedrich, Dagmar, "European Report on Drug Consumption Rooms" (Lisbon, Portugal: European Monitoring Centre on Drugs and Drug Addiction, February 2004)
– Hurley, Susan F., Damien J. Jolley, John M. Kaldor, "Effectiveness of Needle-Exchange Programmes for Prevention of HIV Infection," The Lancet, 1997; 349: 1797-1800, June 21, 1997.
– Stephen W. Hwang, Science and Ideology, Aug 21, 2007. Vol. 1(2), pp.99-101.
– Interventions to prevent HIV risk behaviors. National Institutes of Health Consensus Development Conference Statement. 1997; Feb 11-13. AIDS 2000;14 Suppl 2 S85-96.
– Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005;366(9482):316-8.
– Kerr T, Stoltz JA, Tyndall M, Li K, Zhang R, Montaner J, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ 2006;332(7535):220-2.
– Lomas J. Connecting research and policy. Isuma: Can J Policy Res 2000;1(1):140-4.
– National Commission on AIDS, The Twin Epidemics of Substance Abuse and HIV (Washington DC: National Commission on AIDS, 1991); General Accounting Office, Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy (Washington DC: US Government Printing Office, 1993); Lurie, P. & Reingold, A.L., et al., The Public Health Impact of Needle Exchange Programs in the United States and Abroad (San Francisco, CA: University of California, 1993); Satcher, David, MD, (Note to Jo Ivey Bouffard), The Clinton Administration’s Internal Reviews of Research on Needle Exchange Programs (Atlanta, GA: Centers for Disease Control, December 10, 1993); National Research Council and Institute of Medicine, Normand, J., Vlahov, D. & Moses, L. (eds.), Preventing HIV Transmission: The Role of Sterile Needles and Bleach (Washington DC: National Academy Press, 1995); Office of Technology Assessment of the U.S. Congress, The Effectiveness of AIDS Prevention Efforts (Springfield, VA: National Technology Information Service, 1995); National Institutes of Health Consensus Panel, Interventions to Prevent HIV Risk Behaviors (Kensington, MD: National Institutes of Health Consensus Program Information Center, February 1997).
– "Policy Statement: Reducing the Risk of HIV Infection Associated With Illicit Drug Use," Committee on Pediatric AIDS, Pediatrics, Vol. 117, No. 2, Feb. 2006 (Chicago, IL: American Academy of Pediatrics)
– Sendziuk P., Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist. 2007;24(1):113-29.
– Toumbourou JW, Stockwell T, Neighbors C, Marlatt GA, Sturge J, Rehm J., Interventions to reduce harm associated with adolescent substance use. Lancet. 2007 Apr 21;369(9570):1391-401.
– Urbina I. Alone in a city’s AIDS battle, hoping for backup. New York Times 2007 May 29. Available (accessed 2007 Aug 11).
– Vlahov, David, PhD, and Benjamin Junge, MHSc, "The Role of Needle Exchange Programs in HIV Prevention," Public Health Reports, Volume 113, Supplement 1, June 1998, pp. 75-80.
– Wainberg MA. The need to promote public health in the field of illicit drug use. CMAJ 2006;175(11):1395-6.
– Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006;175(11):1399-404.
– Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 2004;171(7):731-4.
– Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JS, et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354(23):2512-4.
– Wood, Evan, Tyndall, Mark W., Zhang, Ruth, Montaner, Julio S.G., and Kerr, Thomas, "Rate of Detoxification Service Use and its Impact among a Cohort of Supervised Injecting Facility Users," Addiction, Vol. 102
– Wright, Nat M.J., Charlotte N.E. Tompkins, "Supervised Injecting Centres," British Medical Journal, Vol. 328, Jan. 10, 2004
– Zobel, Frank & Françoise Dubois-Arber, "Short appraisal of the role and usefulness of Drug consumption facilities (DCF) in the reduction of drug-related problems in Switzerland: appraisal produced at the request of the Swiss Federal Office of Public Health (Lausanne: University Institute of Social and Preventive Medicine, 2004)
